Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase...

por Nitti, V W, Khullar, V, Kerrebroeck, P, Herschorn, S, Cambronero, J, Angulo, J C, Blauwet, M B, Dorrepaal, C, Siddiqui, E, Martin, N E
Publicado 2013

Development of castration resistance in prostate cancer patients treated with luteinizing hormone-releasing hormone analogues (LHRHa): results of the ANARESISTANCE study

por Angulo, J. C., Ciria Santos, J. P., Gómez-Caamaño, A., Poza de Celis, R., González Sala, J. L., García Garzón, J. M., Galán-Llopis, J. A., Pérez Sampietro, M., Perrot, V., Planas Morin, J.
Publicado 2022